Healthcare >> CEO Interviews >> October 26, 2004
DR. PAUL G. ABRAMS is President and Chief Executive Officer of Ceptyr,
Inc. He was formerly President and CEO of NeoRx Corporation and is on
the Board of Directors of Global Biosciences, a bioremediation company.
He was trained in oncology at the National Cancer Institute and then
became Cancer Expert at the NCI's Biologics Response Modifiers Program.
He received Doctorate degrees in Medicine and in Law from Yale
University. He has published more than 60 scientific papers, edited two
books, and is inventor on more than 13 US patents. Profile
you do.
Dr. Abrams: CEPTYR is uniquely focused on developing drugs against a
class of enzymes in cells that are called
